338483 <common-name>6-(2-chlorophenyl)-7-(4-chlorophenyl)-n-(1,1-dioxothiolan-3-yl)-2-(methylsulfamoyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide</common-name> <description>6-(2-chlorophenyl)-7-(4-chlorophenyl)-n-(1,1-dioxothiolan-3-yl)-2-(methylsulfamoyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide is a chemical compound with the formula C24H21Cl2N5O5S2. With an average molecular weight of 594.50 g/mol, 6-(2-chlorophenyl)-7-(4-chlorophenyl)-n-(1,1-dioxothiolan-3-yl)-2-(methylsulfamoyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>67272017</pubchem-id> <chemical-formula>C24H21Cl2N5O5S2</chemical-formula> <weight>594.5</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T21:35:44Z</created-at> <updated-at type="dateTime">2026-08-30T21:35:44Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CNS(=O)(=O)C1=NN2C(=C(C=NC2=C1C(=O)NC3CCS(=O)(=O)C3)C4=CC=CC=C4Cl)C5=CC=C(C=C5)Cl</moldb-smiles> <moldb-formula>C24H21Cl2N5O5S2</moldb-formula> <moldb-inchi>InChI=1S/C24H21Cl2N5O5S2/c1-27-38(35,36)24-20(23(32)29-16-10-11-37(33,34)13-16)22-28-12-18(17-4-2-3-5-19(17)26)21(31(22)30-24)14-6-8-15(25)9-7-14/h2-9,12,16,27H,10-11,13H2,1H3,(H,29,32)</moldb-inchi> <moldb-inchikey>OGXPEWYKDODYIH-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">593.0361165</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>3</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM334376</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>6-(2-chlorophenyl)-7-(4-chlorophenyl)-n-(1,1-dioxothiolan-3-yl)-2-(methylsulfamoyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Diazines</klass> <subklass>Pyrimidines and pyrimidine derivatives</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0288910</sync-id> <structure-inchikey>OGXPEWYKDODYIH-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>8000000000000010080000000000040000040000000000000038002002410000008000000000000040002000204000000000000440000200000100000000020001000000000000000000100000000010000010080000000000000080000800000920180000000020080000002100000000040020000800000000000000080800004040100000001000000040000000000000004000000082000080000000000020000080000080000000000000100000000000000000000000022000000000010008080000000000200000000000000000000000000040040000000000400000001080000000000000000000800</structure-fingerprint> <structure-pattern-fingerprint>7136e2108d33866081801f6581b8e2021980148281072050a03da2408a24e84c7ca2087f13a200080184c9a810c20102046002a4c08d3265016e657b81b04210c7118c8b129014954a90124013f202208c44c59153311f3f41044d624c22da058d38656f004c1220e2088480dd94024d318680728139c54633183c604751084616641a185efc82080c061250c82c2288793dd81244429e8a562008a060c044d4d1d3109380b4c2720a04c969957c37144ac800028943885058b04ab04cc00a12a06032a5a4981b33198086a45f5542990d090010436070208d700a042a0103609138493418c90124114c4411db9620831850043094c2042e5300908053180246</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKgAAAIABBgBgAAAAAQMHAGAAAAAC ARAAIAAAAAYIACgAAAADAggAKAAAAAMCBkAoAAAAAwQHQCgAAAADAwdAKAAA AAMDBkAoAAAAAwQGQCgAAAADBAZAaAAAAAMDAQdAKAAAAAMDBkAoAAAAAwQG QCgAAAADBAYAKAAAAAMECAAoAAAAAwIHAGgAAAADAgEGAGAAAAADAQYAYAAA AAICBgBgAAAAAgIQACAAAAAGCAAoAAAAAwIIACgAAAADAgYAYAAAAAICBkAo AAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQCgA AAADBBEAIAAAAAEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAME BkBoAAAAAwMBBkBoAAAAAwMBEQAgAAAAAQsAAQABAgACAwgCAgQIAgIFAAUG aAwGB2gMBwhoDAgJaAwJCmgMCgtoDAsMaAwMDWgMDQ4gDg8oAg4QIBARABES ABITABMUABQVCAIUFggCFBcACRggGBloDBkaaAwaG2gMGxxoDBwdaAwdHgAI HyAfIGgMICFoDCEiaAwiI2gMIyRoDCIlAA0FaAwMB2gMFxEAHRhoDCQfaAxC BQAAAAUFBgcMDQYKCwwHCAkFEhEXFBMGGRobHB0YBiAhIiMkHxcEAAAAAAAA ABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:39:15Z</structure-indexed-at> </compound>